This exclusive report provides a thorough analysis of the global DHA Supplements Market. It examines the shift towards AI-driven personalized nutrition, the increasing adoption of sustainable algal-based sources, and the changing insights from various regions. Key elements include competitive analysis, market trends and in-depth evaluations of delivery lifecycles that improve bioavailability. The global DHA Supplements Market size was valued at US$ 1673.3 Million in 2025 and is poised to grow from US$ 1675.3 Million in 2026 to 3055.6 Million by 2033, growing at a CAGR of 7.2% in the forecast period (2026-2033). The report covers segmentation by source type, product form, application, and distribution channel across all major geographies. Regulatory frameworks from bodies such as the FDA and the European Food Safety Authority are also assessed to provide a complete picture of the market landscape.
Market Size (2026)
$1673.3M
Projected (2033)
$3055.6M
CAGR
7.2%
Published
March 2026
Select User License
Selected
PDF Report
USD 4,900
USD 3,200
The DHA Supplements Market is valued at $1673.3M and is projected to grow at a CAGR of 7.2% during 2026 - 2033. North America holds the largest regional share, while Asia-Pacific (10.7%–13.1% CAGR) is the fastest-growing market.
Study Period
2020 - 2033
Market Size (2026)
$1673.3M
CAGR (2026 - 2033)
7.2%
Largest Market
North America
Fastest Growing
Asia-Pacific (10.7%–13.1% CAGR)
Market Concentration
Medium
*Disclaimer: Major Players sorted in no particular order
Artificial Intelligence is changing the DHA Supplements Market in a way. It is helping the industry move from getting oil from the ocean in amounts to using special tanks that are controlled by Artificial Intelligence. This is really helping with making DHA from algae. Artificial Intelligence is using tools like Artificial Neural Networks and XGBoost models to watch and control these tanks. These Artificial Intelligence systems can change things like how light the algae gets what nutrients it gets and how much oxygen is in the tank. They do all of this to help the algae make lipids.
They are really good at guessing how biomass they will get, with up to 97 percent accuracy. This has helped reduce the time and money it takes to make DHA. Now companies can make DHA that's sustainable and does not come from fish. They can sell it for a price that's similar to fish oil and it is always the same high quality. Artificial Intelligence is also changing the way we take care of our brains and hearts.
In 2026 companies are using Artificial Intelligence to look at lots of data about our health like what's in our blood and what our genes are like. They use this data to tell us how DHA we should take. They can even send us messages on our devices to tell us when it is the time to take our supplements. They do this by looking at what we have been eating. When we should take the DHA to help our bodies use it. Artificial Intelligence is also helping to make ways to keep DHA fresh for longer.
It does this by guessing how the DHA will break down over time. All of this is helping to make sure that the DHA supplements we take are really good, for us and that they work well. Artificial Intelligence is the reason why this is all happening.
The DHA Supplements Market is witnessing growth, which is fueled by an increase in consumer awareness regarding its health advantages. DHA, an omega-3 fatty acid, is well-known for its essential contributions to brain, heart and eye health, especially during infant development. This has resulted in a robust demand across various applications, including infant formula, prenatal supplements, and products designed to enhance cognitive and cardiovascular health in adults. A significant trend within the market is the movement towards sustainable and plant-based sources.
Although fish oil continues to be a primary source, there is a growing interest in algal oil, which serves as a vegan alternative. This shift appeals to an expanding demographic of health-conscious consumers and addresses issues related to overfishing and marine pollution. The market is also marked by innovations in product formats, such as gummies, which provide a tasty and convenient substitute for traditional capsules. There is also an increasing demand for high-purity, concentrated products and tailored nutrition solutions.
While North America and Europe remain key markets, the Asia-Pacific region is set for swift growth due to rising disposable incomes and heightened health awareness.
| Year | Market Size (USD Billion) | Period |
|---|---|---|
| 2026 | $1.67T | Forecast |
| 2027 | $1.82T | Forecast |
| 2028 | $1.99T | Forecast |
| 2029 | $2.17T | Forecast |
| 2030 | $2.36T | Forecast |
| 2031 | $2.57T | Forecast |
| 2032 | $2.80T | Forecast |
| 2033 | $3.06T | Forecast |
The DHA supplements market is growing because people are becoming more aware of how omega-3 fatty acids help with brain function, eye health and overall well-being.
Many consumers are adding DHA supplements to their routine especially for pregnancy baby development and elderly health.
There is a growing interest in algal oil, which serves as a vegan alternative. This shift appeals to an expanding demographic of health-conscious consumers and addresses issues related to overfishing and marine pollution.
The market is also marked by innovations in product formats, such as gummies, which provide a tasty and convenient substitute for traditional capsules. There is also an increasing demand for high-purity, concentrated products and tailored nutrition solutions.
One issue is that product quality can vary, which affects consumer trust. Sourcing, purity and formulation methods can make products inconsistent and seem less effective.
It can also be confusing for consumers to know the dosage and which omega-3 source to choose which can impact their buying decisions and long-term usage.
They also look at the price-index volatility of anchovy quotas vs. Scaling algal-fermentation bioreactors to see how it will affect the market.
There are opportunities for growth in the DHA supplements market. For example DHA can be used in consumer segments and product formats. Plant-based and algae-derived DHA are becoming popular among vegetarians and vegans. DHA is also being used more in baby nutrition, prenatal supplements and functional beverages. Companies can differentiate their products by creating targeted formulations for health outcomes and life stages such as DHA supplements for brain health and DHA supplements for heart health. The DHA supplements can support brain function. The DHA supplements can support eye health. The DHA supplements are good, for well-being.
2%, offer brands a cost-effective path to reach personalized nutrition seekers at scale.
Kingdomway Nutrition ECPlaza Network Inc. LTD Stepan Company Novotech Nutraceuticals Arjuna Natural Jiangsu Auqi Marine Biotechnology Co. Aker BioMarine BASF Corporation DSM Cellana Inc. Ltd FEMICO Croda International Plc Pharma Marine AS Clover Corporation Omega Protein Corporation. The market carries a medium concentration level, meaning no single player commands an overwhelming share and competition is driven by differentiation in source sustainability, purity standards, and delivery innovation. In October 2024, Cellana and PhytoSmart signed a definitive merger agreement to strengthen their combined algae-based product portfolio, signaling ongoing consolidation among specialty producers.
Large diversified players such as BASF and DSM compete on scale and formulation breadth, while focused specialists such as Aker BioMarine and Pharma Marine AS compete on traceable, sustainably sourced krill and marine oil credentials.
San Diego, California and Portland, Maine (October 28, 2024) Cellana, Inc. and PhytoSmart Inc., two pioneering leaders in algae-based products and biotechnology, are excited to announce that they have signed a definitive agreement to merge the two companies. Upon closing of the merger, PhytoSmart will become a wholly owned subsidiary of Cellana. Deena Sisitsky, CEO of PhytoSmart, will join the Cellana Board of Directors and will lead the Consumer Products activities for the combined company under the PhytoSmart brand name. The combined company will benefit from an expanding portfolio of commercial products initially in the fast-growing Omega-3 supplement and sustainable nutrition sectors. PhytoSmart's first commercial product is a whole algae pet supplement currently being sold via Amazon.com and through the PhytoSmart corporate website, in addition to select pet stores throughout the United States.
8 September 2025 Croda International Plc ("Croda"), the company that uses smart science to create high-performance ingredients and solutions that improve lives, has recently launched Zenakine, a biotech-based neuroactive ingredient designed to counteract the effects of stress on the skin. This cutting-edge innovative ingredient is based on discoveries made by the translational dermatology team at the University of Manchester, UK and subsequently developed by SkinBiotherapeutics plc, an AIM listed company focused on skin health. As commercial and manufacturing partners, Croda first introduced this cutting edge active earlier this year through a dedicated process at concept line, including a night cream developed specifically for clinical tests – at in-cosmetics Global, the world's largest cosmetics ingredients exhibition.
The global DHA supplements market was valued at USD 1,673.3 million in 2025. It is projected to grow to USD 3,055.6 million by 2033, reflecting strong demand across infant formula, prenatal supplements, and adult cognitive health products. This represents a robust market expansion opportunity for stakeholders.
The DHA supplements market is growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033. Key drivers include increased consumer awareness of omega-3 fatty acids' health benefits, rising prevalence of cognitive and cardiovascular health concerns, and expanding use in functional foods and nutraceuticals.
Infant formula and prenatal supplements represent the largest application segments, driven by growing recognition of DHA's critical role in fetal brain development and infant cognitive function. Adult cognitive and cardiovascular health supplements are the fastest-growing segments, expanding at accelerated rates due to aging populations and wellness trends.
North America holds the largest market share due to high consumer awareness, strong regulatory support, and established distribution networks. Asia-Pacific is the fastest-growing region, with CAGR of 10.7%–13.1%, driven by rising disposable incomes, increasing health consciousness, and expanding infant nutrition markets in China and India.
Major players include Kingdomway Nutrition, ECPlaza Network Inc., Bizen Chemical Co. Ltd., Stepan Company, and Novotech Nutraceuticals. These companies lead through innovation in product formulations, strategic partnerships, and expansion into emerging markets, particularly in Asia-Pacific and Latin America.
Primary growth drivers include rising consumer awareness of DHA's benefits for brain, heart, and eye health, particularly during infant development and aging. Increasing prevalence of lifestyle diseases, growing demand for functional foods, and expanding e-commerce channels for supplement distribution also fuel market expansion.
Key challenges include raw material sourcing sustainability concerns, fluctuating omega-3 ingredient costs, and regulatory compliance complexity across regions. Additionally, market saturation in developed regions and consumer skepticism regarding supplement efficacy pose constraints to growth.
Significant opportunities include AI-driven personalized nutrition solutions, expansion into emerging markets with rising middle-class populations, and development of plant-based algal DHA alternatives to address sustainability concerns. Direct-to-consumer e-commerce channels and clinical validation of cognitive and cardiovascular benefits present additional growth avenues.
Access detailed analysis, data tables, and strategic recommendations.